{
    "nctId": "NCT04688697",
    "briefTitle": "Prepectoral and Subpectoral Implant-based Breast Reconstruction",
    "officialTitle": "A Multicentric, Open-labeled, Prospective, Randomized Controlled Study to Compare the Satisfaction and Safety of the Prepectoral and Subpectoral Implant-based Breast Reconstruction in Patients Receiving Immediate Breast Reconstruction Using Implant Combined With TiLoop\u00ae Bra After Skin Sparing or Nipple-areola Sparing Mastectomy",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Carcinoma, Breast Reconstruction",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "Patients' satisfaction",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. More than 18 years old\n2. Female\n3. Preoperative pathology confirming invasive breast carcinoma or ductal carcinoma in situ\n4. Clinical T1 and T2 (Maximum tumor diameter \u22645 cm)\n5. Clinical ALN negative (Clinical physical examination and ultrasound indicate axillary lymph node negative; Suspected abnormality of axillary lymph node, and fine needle aspiration negative)\n6. No clinical or imaging evidence of distant metastasis\n7. Patients to receive skin sparing mastectomy or nipple sparing mastectomy\n8. BMI \\< 35\n9. Patients with no or mild mastoptosis\n10. Prosthesis to be implanted \\<500 ml\n11. Be able and willing to sign the Informed Consent Form (ICF)\n\nExclusion Criteria:\n\n1. Patients with the breast of moderate-severe mastoptosis, or requiring the use of Wise-pattern or other breast lift methods for subcutaneous mammary gland resection\n2. BMI\\>=35\n3. Patients who have received symmetrical breast surgery on the unaffected side immediately or later\n4. Patients with locally advanced breast cancer to receive neoadjuvant therapy\n5. Patients currently participating in other clinical trials, which may have impact on the participation in this trial\n6. Neoadjuvant therapy has been completed, and there is clear indication of adjuvant radiotherapy after the operation\n7. Previous history of breast cancer (patients with ipsilateral recurrence after breast sparing surgery)\n8. Pregnancy breast-feeding women\n9. History of smoking\n10. Previous history of diabetes",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}